NK cell lines as therapy NK-92 is a human NK-cytotoxic cell line that represents a pure allogeneic activated NK cell source. NK-92 is IL-2 dependent, lacks KIRs, and has been shown to be cytotoxic ...

SR-91 is a natural killer (NK)-resistant leukemic cell line expressing a low level of ICAM-1. Pre-treatment of SR-91 cells with TNF-α or IFN-γ, increased both ICAM-1 (CD54) expression on SR-91 ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy, INKmune™, in a Phase I/II trial (the ...

These therapeutic CAR-NK cells are made from induced pluripotent stem cells derived from healthy donor fibroblast cell lines with centralized manufacturing of a large number of doses per ...

NK cells are part of the innate immune system, a first line of defense that doesn't need to be primed into action. The latest collaboration will focus initially on NK therapies for leukaemia and ...

INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, ...

Infection with hepatitis D viruses causes severe inflammation of the liver. An MHH team has now identified a marker on natural killer cells that is influenced by the anti-inflammatory effectiveness of ...